Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valder R Arruda

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Blood Advances|March 4, 2018
Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog modelRobert A French, Benjamin J Samelson-Jones, Glenn P Niemeyer, et al.
Blood Advances|March 3, 2021
Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variantsBenjamin J Samelson-Jones, Jonathan D Finn, Leslie J Raffini, et al.
American Journal of Hematology|August 13, 2004
Follow-up of sickle cell disease patients with priapism treated by hydroxyureaSara T O Saad, Camila Lajolo, Simone Gilli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2006
Inadvertent germline transmission of AAV2 vector: findings in a rabbit model correlate with those in a human clinical trialJoerg Schuettrumpf, Jian-Hua Liu, Linda B Couto, et al.
The Journal of Clinical Investigation|May 3, 2003
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transferFederico Mingozzi, Yi-Lin Liu, Eric Dobrzynski, et al.
Blood|October 14, 2004
Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelValder R Arruda, Hansell H Stedman, Timothy C Nichols, et al.
Blood Advances|March 14, 2025
Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesisRaghunath Azhwar, Catherine E Richter, Megan S Griffin, et al.
The New England Journal of Medicine|October 23, 2009
X-linked thrombophilia with a mutant factor IX (factor IX Padua)Paolo Simioni, Daniela Tormene, Giulio Tognin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 21, 2009
Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemiaErich V de Paula, Mariane Cristina Flores-Nascimento, Valder R Arruda, et al.
Blood|August 25, 2012
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapyJonathan D Finn, Timothy C Nichols, Nikolaos Svoronos, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Blood Advances|March 4, 2018
Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog modelRobert A French, Benjamin J Samelson-Jones, Glenn P Niemeyer, et al.
Blood Advances|March 3, 2021
Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variantsBenjamin J Samelson-Jones, Jonathan D Finn, Leslie J Raffini, et al.
American Journal of Hematology|August 13, 2004
Follow-up of sickle cell disease patients with priapism treated by hydroxyureaSara T O Saad, Camila Lajolo, Simone Gilli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2006
Inadvertent germline transmission of AAV2 vector: findings in a rabbit model correlate with those in a human clinical trialJoerg Schuettrumpf, Jian-Hua Liu, Linda B Couto, et al.
The Journal of Clinical Investigation|May 3, 2003
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transferFederico Mingozzi, Yi-Lin Liu, Eric Dobrzynski, et al.
Blood|October 14, 2004
Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelValder R Arruda, Hansell H Stedman, Timothy C Nichols, et al.
Blood Advances|March 14, 2025
Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesisRaghunath Azhwar, Catherine E Richter, Megan S Griffin, et al.
The New England Journal of Medicine|October 23, 2009
X-linked thrombophilia with a mutant factor IX (factor IX Padua)Paolo Simioni, Daniela Tormene, Giulio Tognin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 21, 2009
Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemiaErich V de Paula, Mariane Cristina Flores-Nascimento, Valder R Arruda, et al.
Blood|August 25, 2012
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapyJonathan D Finn, Timothy C Nichols, Nikolaos Svoronos, et al.
Pageof 9